Ryanodine receptor channelopathies

被引:52
作者
Benkusky, NA [1 ]
Farrell, EF [1 ]
Valdivia, HH [1 ]
机构
[1] Univ Wisconsin, Sch Med, Dept Physiol, Madison, WI 53706 USA
关键词
ryanodine receptor; malignant hyperthermia; central core disease; heart failure; catecholaminergic polymorphic ventricular; tachycardia;
D O I
10.1016/j.bbrc.2004.08.033
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ryanodine receptors (RyR) are the Ca2+ release channels of sarcoplasmic reticulum that provide the majority of the [Ca2+] necessary to induce contraction of cardiac and skeletal muscle cells. In their cellular environment, RyRs are exquisitely regulated by a variety of cytosolic factors and accessory proteins so that their output signal (Ca2+) induces cell contraction without igniting signaling pathways that eventually lead to contractile dysfunction or pathological cellular remodeling. Here we review how dysfunction of RyRs, most commonly expressed as enhanced Ca2+ release at rest (skeletal muscle) or during diastole (cardiac muscle), appears to be the fundamental mechanism underlying several genetic or acquired syndromes. In skeletal muscle, malignant hyperthermia and central core disease result from point mutations in RYR1, the skeletal isoform of RyRs. In cardiac muscle, RYR2 mutations lead to catecholaminergic polymorphic ventricular tachycardia and other cardiac arrhythmias. Lastly, an altered phosphorylation of the RyR2 protein may be involved in some forms of congestive heart failure. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:1280 / 1285
页数:6
相关论文
共 39 条
  • [1] Ali Syed Z, 2003, Best Pract Res Clin Anaesthesiol, V17, P519, DOI 10.1016/j.bpa.2003.09.012
  • [2] Dilated cardiomyopathy and sudden death resulting from constitutive activation of protein kinase A
    Antos, CL
    Frey, N
    Marx, SO
    Reiken, S
    Gaburjakova, M
    Richardson, JA
    Marks, AR
    Olson, EN
    [J]. CIRCULATION RESEARCH, 2001, 89 (11) : 997 - 1004
  • [3] TWITCHES IN PRESENCE OF ETHYLENE-GLYCOL BIS(BETA-AMINOETHYL ETHER)-N,N'-TETRAACETIC ACID
    ARMSTRONG, CM
    BEZANILLA, FM
    HOROWICZ, P
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1972, 267 (03) : 605 - +
  • [4] Different interactions of cardiac and skeletal muscle ryanodine receptors with FK-506 binding protein isoforms
    Barg, S
    Copello, JA
    Fleischer, S
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1997, 272 (05): : C1726 - C1733
  • [5] Bers D.M., 2001, Excitation-Contraction Coupling and Cardiac Contractile Force, V2th
  • [6] BRODDE OE, 1991, PHARMACOL REV, V43, P203
  • [7] Congenital myopathies
    Bruno C.
    Minetti C.
    [J]. Current Neurology and Neuroscience Reports, 2004, 4 (1) : 68 - 73
  • [8] Manipulating cardiac contractility in heart failure - Data from mice and men
    Dorn, GW
    Molkentin, JD
    [J]. CIRCULATION, 2004, 109 (02) : 150 - 158
  • [9] FABIATO A, 1983, AM J PHYSIOL, V245, P14
  • [10] ABNORMAL RYANODINE RECEPTOR CHANNELS IN MALIGNANT HYPERTHERMIA
    FILL, M
    CORONADO, R
    MICKELSON, JR
    VILVEN, J
    MA, JJ
    JACOBSON, BA
    LOUIS, CF
    [J]. BIOPHYSICAL JOURNAL, 1990, 57 (03) : 471 - 475